2008
DOI: 10.1182/blood-2007-03-081232
|View full text |Cite
|
Sign up to set email alerts
|

BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells

Abstract: IntroductionB cell-activating factor belonging to the TNF family (BAFF) has emerged as an important regulator of B-cell homeostasis and survival: it acts alone or in combination with B-cell receptor (BCR), IL-4, or CD40 ligands. 1-4 BAFF binds 3 different TNF receptors: BCMA (B-cell maturation), 5,6 TACI (transmembrane activator and CAML interactor), 7 and BAFF-R/BR3 (BLys receptor 3). 8 A highly similar homolog (called "a proliferation-inducing ligand" or APRIL) 1 also binds TACI and BCMA but not BAFF-R. 9 BC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
69
1
3

Year Published

2008
2008
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 102 publications
(82 citation statements)
references
References 51 publications
9
69
1
3
Order By: Relevance
“…We show that administration of LV-shBAFF in the CIA mice suppresses the expression of proinflammatory cytokines, such as IL-6, IL-1␤, and IL-23, in joint tissue, an effect possibly contributed predominantly by its inhibition on leukocyte infiltration. In addition, the significant down-regulation of chemokine levels in joint tissues after LV-shBAFF treatment may furthermore suppress the chemotaxis of both T and B cells, a notion reinforced by recent findings that CXCL13 and BAFF synergistically enhance B-cell chemotaxis (29). BAFF genesilenced DCs show defective IL-6 production and display severely impaired capacity in inducing Th17-cell generation in vitro.…”
Section: Discussionmentioning
confidence: 93%
“…We show that administration of LV-shBAFF in the CIA mice suppresses the expression of proinflammatory cytokines, such as IL-6, IL-1␤, and IL-23, in joint tissue, an effect possibly contributed predominantly by its inhibition on leukocyte infiltration. In addition, the significant down-regulation of chemokine levels in joint tissues after LV-shBAFF treatment may furthermore suppress the chemotaxis of both T and B cells, a notion reinforced by recent findings that CXCL13 and BAFF synergistically enhance B-cell chemotaxis (29). BAFF genesilenced DCs show defective IL-6 production and display severely impaired capacity in inducing Th17-cell generation in vitro.…”
Section: Discussionmentioning
confidence: 93%
“…30 Based on this study and other reports that the stromal cell-derived chemokines CXCL12 (SDF-1) and CXCL13 induce chemotaxis in MCL, 31,32 we hypothesized that BAFF may also enhance CXCL12 and CXCL13 chemotaxis of primary MCL cells. Using the chemotaxis assay, we compared MCL cell migration responses to CXCL12 and CXCL13 following incubation with medium only, BAFF or BAFF plus BAFFR-Fc.…”
Section: B-cell Activating Factor Increases Cxcl12-and Cxcl13-dependementioning
confidence: 90%
“…Given the robust expression of LTB4R1 on recruited B2 cells, we next examined whether the LTB4/LTB4R1 axis plays a role in B2 cell chemotaxis. In in vitro Transwell chemotaxis assays (34,37), LTB4 led to a dose-responsive increase in splenic B2 cell migration (Figure 2A), and these effects were absent using splenic B2 cells isolated from Ltb4r1 knockout (hereafter referred to as Ltb4r1KO) mice. In addition, cotreatment with the LTB4R1 inhibitor (CP-105696) completely blocked LTB4-induced B2 cell chemotaxis ( Figure 2B).…”
Section: Resultsmentioning
confidence: 99%
“…In vitro chemotaxis assay. In vitro chemotaxis assays were performed as previously described (34,37). Briefly, ATB2 cells isolated from either HFD-fed WT or Ltb4r1KO mice were placed in the upper chamber of a 5-μm polycarbonate filter, and RPMI with or without LTB4 (Cayman Chemical) was placed in the lower chamber.…”
Section: Methodsmentioning
confidence: 99%